ArticleOncoscience2017

Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis.

Lisa M Julian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.